Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy

被引:51
作者
Basalus, Mounir W. Z. [1 ]
Ankone, Marc J. K. [2 ]
van Houwelingen, K. Gert [1 ]
de Man, Frits H. A. F. [1 ]
von Birgelen, Clemens [1 ,2 ]
机构
[1] Thoraxctr Twente, Dept Cardiol, NL-7513 ER Enschede, Netherlands
[2] Univ Twente, Inst Biomed Technol BMTI, NL-7500 AE Enschede, Netherlands
关键词
Drug-eluting stents; percutaneous coronary interventions; polymer coating; scanning electron microscopy; coronary artery disease; ROUTINE CLINICAL-PRACTICE; CORONARY-ARTERY-DISEASE; BARE-METAL; THROMBOSIS; MULTICENTER; OUTCOMES; TRIALS;
D O I
10.4244/EIJV5I1A24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To classify and quantify post-expansion irregularities in durable polymer-based coatings of drug-eluting stents (DES). Methods and results: Taxus Liberte (TM), Endeavor Sprint (TM), Endeavor Resolute (TM) and Xience V (TM) DES (three samples of each) were explored by light microscopy and scanning electron microscopy (SEM) following expansion at 14 atm in water. Incidence and size of irregularities were measured during thorough quantitative examinations of a 360 SEM images. DES types examined showed a significant difference in the incidence of irregularities (p<0.0001; 6.6 +/- 4.2/image at 60-fold magnification) with typical patterns specific for each DES. All types showed areas with bare metal-aspects, but incidence, shape, and size differed largely: Sprint showed the largest areas. Cracks were only found in Sprint and Resolute, while wrinkles were seen exclusively in Taxus Liberte and Xience V (p<0.0001). The coating of each DES type showed some inhomogeneity of distribution, but the incidence differed (p<0.0001) and was least in Taxus Liberte, which, on the other hand, was the only DES that showed webbing with large bare-metal exposure. Conclusions: The incidence and size of various coating irregularities on different types of DES varied widely. These data may be considered in ongoing discussions on the differences between DES and may serve as reference to compare novel DES.
引用
收藏
页码:157 / 165
页数:9
相关论文
共 33 条
[1]   Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease [J].
Barlis, Peter ;
Kaplan, Sahin ;
Dimopoulos, Konstantinos ;
Ferrante, Giuseppe ;
Di Mario, Carlo .
CARDIOLOGY, 2008, 111 (04) :270-276
[2]  
Bertrand OF, 2008, J INVASIVE CARDIOL, V20, P99
[3]   Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions [J].
Colombo, A ;
Drzewiecki, J ;
Banning, A ;
Grube, E ;
Hauptmann, K ;
Silber, S ;
Dudek, D ;
Fort, S ;
Schiele, F ;
Zmudka, K ;
Guagliumi, G ;
Russell, ME .
CIRCULATION, 2003, 108 (07) :788-794
[4]   Drug-eluting stent update 2007 part I: a survey of current and future generation drug-eluting stents: meaningful advances or more of the same? [J].
Daemen, Joost ;
Serruys, Patrick W. .
CIRCULATION, 2007, 116 (03) :316-328
[5]   Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study [J].
Daemen, Joost ;
Wenaweser, Peter ;
Tsuchida, Keiichi ;
Abrecht, Linda ;
Sophia, Vaina ;
Morger, Cyrill ;
Kukreja, Neville ;
Jueni, Peter ;
Sianos, Georgios ;
Hellige, Gerrit ;
van Domburg, Ron T. ;
Hess, Otto M. ;
Boersma, Eric ;
Meier, Bernhard ;
Windecker, Stephan ;
Serruys, Patrick W. .
LANCET, 2007, 369 (9562) :667-678
[6]   Biodegradable drug-eluting stents: promises and pitfalls [J].
Di Mario, Carlo ;
Ferrante, Giuseppe .
LANCET, 2008, 371 (9616) :873-874
[7]   Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents:: a prospective, non-randomised multicentre trial [J].
Erbel, Raimund ;
Di Mario, Carlo ;
Bartunek, Jozef ;
Bonnier, Johann ;
de Bruyne, Bernard ;
Eberli, Franz R. ;
Erne, Paul ;
Haude, Michael ;
Heublein, Bernd ;
Horrigan, Mark ;
Ilsley, Charles ;
Boese, Dirk ;
Koolen, Jacques ;
Luescher, Thomas F. ;
Weissman, Neil ;
Waksman, Ron .
LANCET, 2007, 369 (9576) :1869-1875
[8]  
*FDA, 2008, FDA SUMM SAF EFF DAT
[9]  
*FDA, 2007, FDA SUMM SAF EFF DAT, P21
[10]   Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization [J].
Finn, Aloke V. ;
Joner, Michael ;
Nakazawa, Gaku ;
Kolodgie, Frank ;
Newell, John ;
John, Mike C. ;
Gold, Herman K. ;
Virmani, Renu .
CIRCULATION, 2007, 115 (18) :2435-2441